WRAP53 抗体 (AA 285-390) (FITC)
Quick Overview for WRAP53 抗体 (AA 285-390) (FITC) (ABIN919948)
抗原
See all WRAP53 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 285-390
-
交叉反应
- 小鼠, 大鼠
-
预测反应
- Human,Horse,Rabbit
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human WDR79/TCAB1
-
亚型
- IgG
-
-
-
-
应用备注
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
有效期
- 12 months
-
-
- WRAP53 (WD Repeat Containing, Antisense To TP53 (WRAP53))
-
别名
- TCAB1
-
背景
-
Synonyms: FLJ10385, TCAB1, telomerase Cajal Body protein 1, WD repeat containing protein 79, WRAP53, WDR79/TCAB1, WAP53_HUMAN.
Background: WDR79 contains six WD (tryptophan-aspartate) repeat domains found in a number of proteins that function as adaptor molecules in signal transduction and cytoskeletal organization. The WD repeat is defined by four or more repeating units of a conserved core of approximately 40 amino acids ending with tryptophan-aspartic acid (WD). WD repeats may serve as sites of protein-protein interaction for adaptor proteins and facilitate multiprotein complex formation. The function of the WDR79 protein has not been characterized, however significant and consistent single nucleotide polymorphisms in the WDR79 gene have been found to be associated with ER negative breast cancer.
-
基因ID
- 3135
-
UniProt
- Q9BUR4
-
途径
- Telomere Maintenance
抗原
-